|
Volumn 35, Issue 1, 1999, Pages 2-8
|
Vascular endothelial growth factor: An important angiogenic mediator in bladder cancer
|
Author keywords
Angiogenesis; Bladder cancer; Intravesical therapy; Recurrence, bladder cancer; Vascular endothelial growth factor
|
Indexed keywords
BLOCKING ANTIBODY;
COMPLEMENTARY RNA;
SURAMIN;
TUMOR MARKER;
VASCULOTROPIN;
VASCULOTROPIN RECEPTOR;
ANGIOGENESIS;
BLADDER CANCER;
BLADDER TUMOR;
CANCER GROWTH;
CANCER INVASION;
CANCER RECURRENCE;
CANCER THERAPY;
DENSITY;
GENE EXPRESSION;
HUMAN;
INTRAVESICAL DRUG ADMINISTRATION;
METASTASIS;
PHENOTYPE;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
URINALYSIS;
VASCULARIZATION;
ENDOTHELIAL GROWTH FACTORS;
ENDOTHELIUM, VASCULAR;
HUMANS;
LYMPHOKINES;
NEOPLASM RECURRENCE, LOCAL;
NEOVASCULARIZATION, PATHOLOGIC;
URINARY BLADDER NEOPLASMS;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
EID: 0033054499
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000019811 Document Type: Review |
Times cited : (55)
|
References (87)
|